Filed: 8/13/2026ACC: 0000905148-26-003614
📋 What this filing means
DAVERN CAPITAL PARTNERS, LP filed this quarterly 13F‑HR report disclosing 15 equity positions with a total reported market value of $586.54M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
15
Positions
$586.54M
Total AUM (reported)
10.28M
Total Shares
Allocation by class
COM$221.10M37.7%
SPONSORED ADS$128.56M21.9%
SHS$68.41M11.7%
SHS CLASS A$64.81M11.0%
COM PAR $.01$59.69M10.2%
CL A$21.40M3.6%
COM SHS$13.91M2.4%
Portfolio Concentration
Top 3$203.42M34.7%
4–10$305.47M52.1%
11–25$77.65M13.2%
Top 3 weight
34.7%
Top 10 weight
86.8%
Voting Authority Distribution
Total shares with voting rights: 10.28M
Sole
Full voting authority
442.44K
shares
% of voting shares4.3%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
9.84M
shares
% of voting shares95.7%
Investment Discretion (by position count)
Sole15
Shared0
Other0
Dominant voting typeNone · 95.7% of voting shares
Institutional Holdings15
Rows:
BIONTECH SE
SOLEShares754.55K
TypeSH
Market value$70.21M
11.97%
Sole
31.97K
Shared
0.00
None
722.58K
ROIVANT SCIENCES LTD
SOLEShares1.93M
TypeSH
Market value$68.41M
11.66%
Sole
82K
Shared
0.00
None
1.85M
ROYALTY PHARMA PLC
SOLEShares1.16M
TypeSH
Market value$64.81M
11.05%
Sole
48.97K
Shared
0.00
None
1.11M
IONIS PHARMACEUTICALS INC
SOLEShares798.71K
TypeSH
Market value$63.33M
10.80%
Sole
33.83K
Shared
0.00
None
764.88K
INSMED INC
SOLEShares559.82K
TypeSH
Market value$59.69M
10.18%
Sole
23.75K
Shared
0.00
None
536.07K
REGENERON PHARMACEUTICALS
SOLEShares92.64K
TypeSH
Market value$57.76M
9.85%
Sole
3.92K
Shared
0.00
None
88.72K
LEGEND BIOTECH CORP
SOLEShares1.19M
TypeSH
Market value$34.41M
5.87%
Sole
50.48K
Shared
0.00
None
1.14M
ALNYLAM PHARMACEUTICALS INC
SOLEShares113.08K
TypeSH
Market value$34.04M
5.80%
Sole
4.79K
Shared
0.00
None
108.29K
NATERA INC
SOLEShares118.97K
TypeSH
Market value$32.30M
5.51%
Sole
4.97K
Shared
0.00
None
114K
STRUCTURE THERAPEUTICS INC
SOLEShares446.06K
TypeSH
Market value$23.94M
4.08%
Sole
18.63K
Shared
0.00
None
427.43K
MINERALYS THERAPEUTICS INC
SOLEShares858.75K
TypeSH
Market value$23.17M
3.95%
Sole
35.87K
Shared
0.00
None
822.88K
VERA THERAPEUTICS INC
SOLEShares498.83K
TypeSH
Market value$21.40M
3.65%
Sole
21.16K
Shared
0.00
None
477.67K
GENERATE BIOMEDICINES INC
SOLEShares824.68K
TypeSH
Market value$13.91M
2.37%
Sole
42.52K
Shared
0.00
None
782.15K
PROCEPT BIOROBOTICS CORP
SOLEShares464.92K
TypeSH
Market value$10.50M
1.79%
Sole
19.70K
Shared
0.00
None
445.22K
AVALO THERAPEUTICS INC
SOLEShares468.67K
TypeSH
Market value$8.66M
1.48%
Sole
19.85K
Shared
0.00
None
448.81K
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BIONTECH SESOLE | SPONSORED ADS | 754.55K | SH | $70.21M 11.97% | 31.97K | 0.00 | 722.58K |
ROIVANT SCIENCES LTDSOLE | SHS | 1.93M | SH | $68.41M 11.66% | 82K | 0.00 | 1.85M |
ROYALTY PHARMA PLCSOLE | SHS CLASS A | 1.16M | SH | $64.81M 11.05% | 48.97K | 0.00 | 1.11M |
IONIS PHARMACEUTICALS INCSOLE | COM | 798.71K | SH | $63.33M 10.80% | 33.83K | 0.00 | 764.88K |
INSMED INCSOLE | COM PAR $.01 | 559.82K | SH | $59.69M 10.18% | 23.75K | 0.00 | 536.07K |
REGENERON PHARMACEUTICALSSOLE | COM | 92.64K | SH | $57.76M 9.85% | 3.92K | 0.00 | 88.72K |
LEGEND BIOTECH CORPSOLE | SPONSORED ADS | 1.19M | SH | $34.41M 5.87% | 50.48K | 0.00 | 1.14M |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 113.08K | SH | $34.04M 5.80% | 4.79K | 0.00 | 108.29K |
NATERA INCSOLE | COM | 118.97K | SH | $32.30M 5.51% | 4.97K | 0.00 | 114K |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 446.06K | SH | $23.94M 4.08% | 18.63K | 0.00 | 427.43K |
MINERALYS THERAPEUTICS INCSOLE | COM | 858.75K | SH | $23.17M 3.95% | 35.87K | 0.00 | 822.88K |
VERA THERAPEUTICS INCSOLE | CL A | 498.83K | SH | $21.40M 3.65% | 21.16K | 0.00 | 477.67K |
GENERATE BIOMEDICINES INCSOLE | COM SHS | 824.68K | SH | $13.91M 2.37% | 42.52K | 0.00 | 782.15K |
PROCEPT BIOROBOTICS CORPSOLE | COM | 464.92K | SH | $10.50M 1.79% | 19.70K | 0.00 | 445.22K |
AVALO THERAPEUTICS INCSOLE | COM NEW | 468.67K | SH | $8.66M 1.48% | 19.85K | 0.00 | 448.81K |